Braveheart Bio

Transforming the care of hypertrophic cardiomyopathy and related conditions.

Braveheart Bio is a clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is advancing BHB-1893 through late-stage clinical development with the goal of establishing a new standard of care.